ImStar Therapeutics Overview

  • Founded

  • 2012

Founded
  • Status

  • Private

  • Employees

  • 4

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 5

ImStar Therapeutics General Information

Description

Developer of biotechnology-based therapies designed to treat patients with amyotrophic lateral sclerosis disease. The company's therapies are used for the treatment of Alzheimer's, Parkinson's disease and dementia, enabling healthcare providers to cure diseases of their patients efficiently.

Contact Information

Website
www.imstartx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1285 West Broadway
  • Suite 600
  • Vancouver, British Columbia V6H 3X8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImStar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 29-Oct-2020 00.000 Completed Generating Revenue
3. Seed Round 12-Jun-2016 00.00 00.000 Completed Generating Revenue
2. Seed Round 01-Jan-2014 $2.16M $2.16M Completed Startup
1. Seed Round 01-Sep-2012 Completed Startup
To view ImStar Therapeutics’s complete valuation and funding history, request access »

ImStar Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology-based therapies designed to treat patients with amyotrophic lateral sclerosis disease. The co
Biotechnology
Vancouver, Canada
4 As of 2023
00.000
0000000000 0 00.000

000 00

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000 000000000
Durham, NC
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
0000 000000000
Clarksville, MD
0 As of 0000
00.000
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImStar Therapeutics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
T3D Therapeutics Venture Capital-Backed Durham, NC 00 000.00 00000000000 000.00
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 00000000000
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
0000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Framingham, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 26 competitors. Get the full list »

ImStar Therapeutics Patents

  • 12

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

ImStar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190315798-A1 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
AU-2014352629-B2 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
AU-2014352629-A1 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
CA-2931064-A1 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
CA-2931064-C Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 C07J71/001
To view ImStar Therapeutics’s complete patent history, request access »

ImStar Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Agnes Chan Ph.D Chief Operating Officer
You’re viewing 1 of 6 executive team members. Get the full list »

ImStar Therapeutics Board Members (7)

Name Representing Role Since
Elizabeth Douville Ph.D AmorChem Board Member 000 0000
You’re viewing 1 of 7 board members. Get the full list »

ImStar Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImStar Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AmorChem Venture Capital Minority 000 0000 000000 0
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
AviTx Corporation Minority 000 0000 000000 0
BDC Capital Growth/Expansion Minority 000 0000 000000 0
eFund (Angel investing) Angel Group Minority 000 0000 000000 0
To view ImStar Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial